You just read:

Imprimis Pharmaceuticals Announces Plans to Launch IV Free™ Conscious Sedation and New Compounded Triple Drop Formulations at Leading Cataract and Refractive Surgeons Meeting

News provided by

Imprimis Pharmaceuticals, Inc.

05 May, 2016, 08:30 ET